整体关节整形术与膜心脏置换患者手术并发症之间的关联:一项观察性研究
Amir Human Hoveidaei1, Sina Esmaeili2, Homina Saffar3
1International Center for Limb Lengthening, Rubin Institute for Advanced Orthopedics, Sinai Hospital of Baltimore, Baltimore, MD, USA.
Arthroplasty today
|July 23, 2025
概括
心置换 (VHR) 没有增加关节整形术后的并发症. 然而,VHR患者在全膝关节整形术 (TKA) 和中风后感染的风险更高,特别是最近的VHR患者.
科学领域:
- 整形外科手术 整形外科手术
- 心脏病学 心脏病学
- 麻醉学 麻醉学
背景情况:
- 心置换 (VHR) 在非心脏手术中增加了风险.
- 关于VHR后的全关节关节整形术 (TJA) 结果的数据有限.
研究的目的:
- 为了评估患者之前的VHR的TJA结果.
- 为了比较VHR患者和对照人群之间的并发症率.
主要方法:
- 回顾性队列研究 (2010-2022年).
- 已确定接受全关节整形术 (THA) 和全膝关节整形术 (TKA) 的患者.
- 用于VHR和对照组的倾向得分匹配.
主要成果:
- 在VHR的THA患者中没有增加并发症.
- 患有VHR的TKA患者表现出更高的周围假肢关节感染 (PJI) 率 (OR=1.54).
- 在TKA发生后3个月内的VHR增加了PJI风险 (OR=4.71);VHR3-6个月前增加了中风风险 (OR=2.61).
结论:
- VHR与增加的THA并发症没有关联.
- 在TKA之后,VHR增加了PJI的风险,特别是最近.
- 在TKA之前的VHR增加了脑血管事故的风险.
相关概念视频
Aortic Regurgitation III: Medical Management
45
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
45
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
65
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
65
Mitral Valve Prolapse II: Assessment and Management
43
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
43
Rheumatic Heart Disease III: Medical Management
33
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
33
Rheumatic Heart Disease I: Introduction
46
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
46
Rheumatic Heart Disease IV: Nursing Management
38
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
38


